Genprex

$3.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.75%) Today
-$0.01 (-0.25%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Genprex and other stocks, options, and ETFs commission-free!

About GNPX

Genprex, Inc. Common Stock, also called Genprex, is a clinical-stage gene therapy company focused on developing potentially life-changing technologies for patients with cancer and diabetes.

CEO
J. Rodney Varner
Employees
12
Headquarters
Austin, Texas
Founded
2009
Market Cap
178.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.14M
High Today
$4.07
Low Today
$3.88
Open Price
$4.05
Volume
515.61K
52 Week High
$7.72
52 Week Low
$1.95

GNPX Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 28, Pre-Market

You May Also Like

VTIQ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure